Andere Sprachen Sera Prognostics, Inc.

Aktien

A3CU1F

US81749D1072

SERA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.06.2024			% 5 Tage	% 1. Jan.
5.92 ^USD	+3.50%		-10.98%	-1.00%

08.05.	Transcript : Sera Prognostics, Inc., Q1 2024 Earnings Call, May 08, 2024
08.05.	Sera Prognostics, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES	28.05.
Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS	08.05.
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024	29.04.
Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing	28.03.
Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing	27.03.
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q4 Revenue $41,000	20.03.
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20.03.
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20.03.
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS	20.03.
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024	04.03.
Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference	29.02.
Sector Update: Health Care Stocks Mixed Late Afternoon	06.12.
Top Midday Gainers	06.12.
Sector Update: Health Care Stocks Rise in Afternoon Trading	06.12.
Sector Update: Health Care	06.12.
Sera Prognostics Says Study of Preterm Birth Prevention Strategy Met Primary Endpoint Criteria; Shares Surge	06.12.
SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS	06.12.
Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success	06.12.
SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE	22.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sera Prognostics, Inc.

Aktien

A3CU1F

US81749D1072

SERA

Andere Sprachen

Filter